93648 ⎘
Thiocarboxylic acids; Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS
#2SINGLE-MOLECULE PEPTIDE SEQUENCING USING XANTHATE AMINO ACID REACTIVE GROUPS
#3THIOESTER CATIONIC LIPIDS
#4CYSTEAMINE AND/OR CYSTAMINE PRODRUGS
#5Cationic Lipid Compound and Composition for Delivery of Nucleic Acids and Use Thereof
#6COMPOUNDS AND METHODS
#7Succinate prodrug, compositions containing the succinate prodrug and uses thereof
#8DI-THIOESTER CATIONIC LIPIDS
#9Succinate prodrug, compositions containing the succinate prodrug and uses thereof
#10Production processes of S- and O-diacylated gamma-glutamyl-cysteamine prodrugs
#11High penetration drugs and their compositions thereof for treatment of Parkinson diseases
#12Thioester cationic lipids
#13Cell-permeable succinate compounds
#14Method for functionalizing carbon nanoparticles and compositions
#15Process for preparing aminothiol ester compounds and salts thereof
#16Process for the preparation of a sulfur-amine
#17High penetration drugs and their compositions thereof for treatment of Parkinson diseases
#18Cell-permeable succinate compounds
#19Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
#20NEW PROCESS
#21High penetration drugs and their compositions thereof for treatment of parkinson diseases
#22NEW PROCESS
#23Dye-Sensitized Solar Cell
#24Bimesogenic Compounds and Mesogenic Media
#25PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION COMPRISING AN APOLIPOPROTEIN PEPTIDE/PHOSPHOLIPID COMPLEX
#26LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS
#27Process
#28Process
#29Trans-2-decenoic acid derivative and pharmaceutical agent containing the same
#30Compound, composition and uses thereof
#31NEW PROCESS
#32NOVEL PROCESS
#33Enantiomerically pure amines
#34CETP activity inhibitors
#35Process for the preparation of cyclohexanecarboxylic acid derivatives
#36FUNGICIDAL 2-(BICYCLIC ARYLOXY)CARBOXAMIDES
#37Process
#38New Process
#39PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION
#40THIOL-CONTAINING COMPOUNDS FOR THE REMOVAL OF ELEMENTS FROM CONTAMINATED MILIEU AND METHODS OF USE
#41NOVEL PROCESS
#42Aziridine aldehydes, aziridine-conjugated amino derivatives, aziridine-conjugated biomolecules and processes for their preparation
#43CETP ACTIVITY INHIBITORS
#44Compounds
#45ACETYL 2-HYDROXY-1,3-DIAMINOALKANES
#46FLAVOURING A FOODSTUFF BY INCORPORATING AN EFFECTIVE AMOUNT OF AT LEAST ONE COMPOUND OF THE FORMULA R1-S-R2 IN WHICH R1 AND R2 REPRESENT A SPECIFIC ATOM OR GROUP
#47Process
#48Compounds that stimulate glucose utilization and methods of use
#49Process for cyclohexanecarboxylic acid derivatives
#50Process for the preparation of CETP(1)
#51Novel Inhibitors of Histone Deacetylase for the Treatment of Disease
#52PROCESS FOR THE PREPARATION OF CETP(1)
#53CETP activity inhibitors
#54Acetyl 2-hydroxy-1, 3-diaminoalkanes
#55INHIBITORS OF HISTONE DEACETYLASE FOR THE TREATMENT OF DISEASE
#56Acylated aminopropanediols and analogues and therapeutic uses thereof
#57Sulfonamides as inhibitors of histone deacetylase for the treatment of disease
#58Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
#59Oxime ester photoinitiators
#60Compounds that stimulate glucose utilization and methods of use
#61Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease